Sotera Health Company (NASDAQ:SHC) Receives Average Rating of “Moderate Buy” from Brokerages

Sotera Health Company (NASDAQ:SHC) has been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $20.25.

SHC has been the subject of several research analyst reports. Barclays lifted their price objective on Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. UBS Group set a $19.00 price objective on shares of Sotera Health in a research report on Wednesday, June 24th. Piper Sandler reiterated an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 15.36% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Sotera Health

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Empowered Funds LLC lifted its stake in Sotera Health by 11.1% during the 1st quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock valued at $332,000 after acquiring an additional 2,845 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Sotera Health by 14.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock valued at $3,999,000 after purchasing an additional 43,471 shares during the last quarter. Acadian Asset Management LLC lifted its position in shares of Sotera Health by 125.5% during the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after purchasing an additional 14,018 shares in the last quarter. Creative Planning lifted its position in shares of Sotera Health by 15.3% during the second quarter. Creative Planning now owns 20,186 shares of the company’s stock valued at $224,000 after purchasing an additional 2,673 shares in the last quarter. Finally, Invesco Ltd. boosted its holdings in Sotera Health by 4.2% during the second quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock worth $3,549,000 after purchasing an additional 12,758 shares during the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Trading Down 0.7%

NASDAQ:SHC opened at $17.98 on Thursday. Sotera Health has a 52 week low of $11.00 and a 52 week high of $19.85. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. The firm’s fifty day moving average is $17.00 and its 200-day moving average is $16.32. The firm has a market cap of $5.13 billion, a P/E ratio of 43.85 and a beta of 1.77.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. The business had revenue of $321.38 million during the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Equities analysts expect that Sotera Health will post 0.87 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.